Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use

Personalized dendritic cell- (DC-) based vaccination has proven to be safe and effective as second-line therapy against various cancer types. In terms of overall survival, there is still room for improvement of DC-based therapies, including the development of more immunostimulatory DC vaccines. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Van den Bergh, J. M. J., Smits, E. L. J. M., Versteven, M., De Reu, H., Berneman, Z. N., Van Tendeloo, V. F. I., Lion, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530419/
https://www.ncbi.nlm.nih.gov/pubmed/28785596
http://dx.doi.org/10.1155/2017/1975902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530419/
https://www.ncbi.nlm.nih.gov/pubmed/28785596
http://dx.doi.org/10.1155/2017/1975902

Ejemplares similares